Phase II study of AMSA in patients with metastatic breast cancer: a Cancer and Leukemia Group B study.
D000328:Adult; D000368:Aged; D000609:Aminoacridines / Q000627:therapeutic use*; D000677:Amsacrine; D000970:Antineoplastic Agents / Q000627:therapeutic use* / Q000633:toxicity; D001943:Breast Neoplasms / Q000188:drug therapy*; D004341:Drug Evaluation; D005260:Female; D006801:Humans; D008875:Middle Aged; D009362:Neoplasm Metastasis
D000609:Aminoacridines; D000970:Antineoplastic Agents; D000677:Amsacrine